Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Anaphylaxis Market?

The market for anaphylaxis has seen robust growth in recent times. The market is forecasted to expand from $3.24 billion in 2024 to $3.51 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.4%. Factors contributing to the growth during the historic period include an increase in food allergies, heightened awareness of anaphylaxis, advancements in healthcare infrastructure, improved diagnosis and management strategies, and the wider availability of epinephrine auto-injectors.

What Growth Rate Is Forecasted for the Anaphylaxis Market by 2029?

The market size for anaphylaxis is predicted to experience robust advancement in the upcoming years, expanding to a total of $4.81 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. The projected growth within this period is due to factors such as escalating urbanization and shifts in lifestyle, an increasing occurrence of anaphylaxis cases, elevating disposable incomes in emerging markets, government support for allergy research, and advancements in emergency treatment delivery systems. The notable trends within this forecast period are heightened demand for injectable auto-injectors, the incorporation of digital health solutions for anaphylaxis management, pronounced emphasis on product affordability, upsurge in preventative treatments and vaccines, and a growing use of biologics in allergy treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Which Key Companies Are Shaping the Future of the Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Which Factors Are Driving Demand in the Anaphylaxis Industry?

The escalating occurrence of food allergies is projected to spur the expansion of the anaphylaxis market. Such allergies are immune responses instigated by specific foods, prompting symptoms from mild to grave, encompassing potentially fatal anaphylaxis. Factors like altered eating habits, environmental impacts, and increased cognizance and diagnosis contribute to the growing occurrence of these allergies. Treatment for Anaphylaxis offers crucial, life-saving aid to food allergic patients by promptly inverting severe allergic reactions, decreasing symptoms such as swelling, difficulty in breathing, and a drop in blood pressure. This ensures prompt stabilisation, prevents possible lethal outcomes and equips patients with methods for prompt reaction in subsequent allergic episodes. For example, The World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, reported in September 2024, that about 220 million individuals worldwide suffer from food allergies. A single food item may contain multiple allergens, and people might be allergic to numerous types of food. Furthermore, in May 2024, the Patterns and Prevalence of Adult Food Allergy (PAFA) report by the Food Standards Agency (FSA), a UK-based non-ministerial department, revealed that over 30% of adults had adverse reactions to food, with clinical assessments validating food allergies in an estimated 6% of UK adults, translating to approximately 2.4 million individuals. Hence, the escalating occurrence of food allergies is augmenting the growth of the anaphylaxis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

How Is the Anaphylaxis Market Segmented by Several Divisions?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers

5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What are the Emerging Market Trends Driving the Growth of the Anaphylaxis Industry?

Key players in the anaphylaxis market are investing in creating state-of-the-art epinephrine nasal sprays that ensure quick and effective medication delivery during crisis situations. Epinephrine nasal spray, a medical tool that transports epinephrine or adrenaline via the nasal passage, is a remedy for serious allergy reactions such as anaphylaxis. As an example, ARS Pharmaceuticals, an American biotech firm, reported in August 2024 that the US government agency, the Food and Drug Administration, had given approval to their product Neffy (epinephrine nasal spray), making it the initial and sole non-needle treatment for Type I allergy reactions, including anaphylaxis. This ground-breaking nasal spray offers a non-intrusive substitute to conventional epinephrine autoinjectors, making it a possibly more easy-to-access option for emergency therapy. Neffy’s objective is to elevate patient adherence by removing the need for needles, facilitating the fast delivery of life-saving epinephrine during critical allergy reactions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Regions Are Driving Growth in the Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096

This Report Delivers Insight On:

1. How big is the anaphylaxis market, and how is it changing globally?

2. Who are the major companies in the anaphylaxis market, and how are they performing?

3. What are the key opportunities and risks in the anaphylaxis market right now?

4. Which products or customer segments are growing the most in the anaphylaxis market?

5. What factors are helping or slowing down the growth of the anaphylaxis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model